Company Overview
Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company operates through three segments: Performance Chemicals, Fuel Specialties, and Oilfield Services. It offers specialty chemical products used as additives in diesel, jet, marine, fuel oil, and other fuels used in the operation of commercial trucking, marine and aviation engines, power station generators, heating oil, and other industrial machinery applications. It also provides technology-based solutions for customers' processes or products in personal care, home care, agrochemical, construction, mining, and other industrial markets. In addition, the company develops and markets chemical solutions for drilling, completion, production, drag reducing agents, and oil and gas applications. It serves large multinational companies, manufacturers of personal and home care products and global mining, agriculture and building products, and other industrial companies; national and multinational oil companies, fuel marketers and retailers, fuel terminals, marine lines, coating and plastics producers, and other heavy industrial end-users; and multinational public, independent exploration and production, and oilfield services companies. The company was formerly known as Octel Corp. and changed its name to Innospec Inc. in January 2006. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado.
Why Investors Should Care
Net profit has compounded at 62.9% per year over the last five years.
Trades at a P/E of 17.8, below the sector median of 22.9.
Offers a dividend yield of 2.07%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $1.78B (-3.7% YoY).
- Trailing 12 Months Year-on-year growth — revenue +2.8%, earnings -6.9%.
- 5-Year Trend Long-term compounding — revenue CAGR 7.0%, profit CAGR 62.9%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 7.04% |
| 1 Year: | 2.80% |
Compounded Profit Growth
| 5 Years: | 62.88% |
| 1 Year: | -6.90% |
Stock Price Performance
| 1 Year: | -4.46% |
| 6 Months: | +3.20% |
| 3 Months: | +7.88% |
| 1 Month: | -4.91% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)49.59 · Neutral
P/E of 17.83 is below the sector median of 22.91 — relatively cheaper than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Profit CAGR of 62.9% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Basic Materials).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | IOSP Innospec Inc. R2K | 81.64 | 17.83 | $2.01B | 2.07% | 8.80% | 8.69% | 7.04% | 62.88% |
| 2 | LIN Linde plc NDXSPX | 522.54 | 34.65 | $241.59B | 1.22% | 12.46% | 18.23% | 13.90% | 18.47% |
| 3 | NEM Newmont Corporation SPX | 94.75 | 12.29 | $101.15B | 1.04% | - | 25.83% | 6.53% | 20.15% |
| 4 | FCX Freeport-McMoRan Inc. SPX | 61.95 | 32.78 | $89.06B | 0.88% | 12.50% | 15.63% | 1.35% | -1.26% |
| 5 | SHW The Sherwin-Williams Company SPX | 328.50 | 31.56 | $81.02B | 1.01% | 21.93% | 60.72% | 6.18% | 8.26% |
| 6 | ECL Ecolab Inc. SPX | 269.75 | 36.55 | $75.92B | 1.10% | 14.29% | 22.43% | 6.17% | 9.18% |
| 7 | CRH CRH plc SPX | 103.91 | 19.28 | $69.43B | 1.47% | 10.97% | 15.81% | 6.41% | 9.30% |
| 8 | APD Air Products and Chemicals, Inc. SPX | 299.40 | 31.55 | $66.67B | 2.57% | -0.62% | 12.35% | -1.77% | -39.16% |
| 9 | CTVA Corteva, Inc. SPX | 84.91 | 45.90 | $56.79B | 0.95% | - | 5.14% | 2.86% | 9.94% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2013 | Jun 2013 | Sep 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | 326.30M | 332.40M | 360.70M | 358.10M | 363.10M | 388.30M | 362.40M | 371.90M | 372.30M | 244.90M | 265.10M | 339.60M | 354.50M | 376.10M | 472.40M | 467.60M | 513.00M | 509.60M | 480.40M | 464.10M | 500.20M | 435.00M | 443.40M | 440.80M | 439.70M | 441.90M | 453.20M |
| Gross Profit | 63.80M | 59.40M | 57.40M | 65.70M | 68.60M | 73.60M | 81.80M | 87.50M | 90.40M | 76.20M | 85.50M | 79.20M | 90.90M | 105.10M | 98.80M | 104.50M | 102.80M | 111.00M | 117.80M | 111.10M | 119.10M | 113.90M | 59.10M | 78.70M | 100.80M | 108.30M | 112.90M | 139.30M | 139.80M | 156.00M | 147.80M | 150.40M | 137.20M | 155.70M | 126.90M | 124.10M | 125.10M | 123.20M | 116.70M | 123.50M |
| Operating Income | 22.20M | 22.30M | 19.50M | 18.00M | 25.30M | 25.20M | 23.40M | 57.40M | 41.20M | 25.60M | 28.60M | 18.90M | 25.30M | 33.50M | 29.00M | 28.90M | 28.30M | 33.40M | 36.20M | 31.70M | 38.20M | 40.90M | -53.40M | 16.80M | 28.20M | 37.00M | 31.40M | 44.30M | 46.30M | 50.10M | 41.00M | 34.20M | 41.90M | 50.50M | 40.70M | 45.60M | 42.50M | 34.30M | 5.90M | 36.50M |
| Net Income | 18.00M | 17.10M | 14.00M | 16.90M | 18.50M | 20.80M | 17.90M | 34.50M | 35.60M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 32.80M | - | - | 30.40M |
| Diluted EPS | 0.75 | 0.71 | 0.58 | 0.69 | 0.75 | 0.83 | 0.72 | 1.40 | 1.45 | 0.77 | 1.18 | 0.47 | 0.70 | 1.06 | 0.95 | 0.90 | 0.89 | 0.84 | 1.17 | 0.90 | 1.22 | 1.34 | -1.62 | 0.51 | 0.94 | 0.90 | 0.94 | 1.46 | 1.29 | 1.55 | 1.33 | 1.16 | 1.57 | 1.65 | 1.24 | 1.33 | 1.31 | 0.94 | 0.52 | 1.22 |
| R&D Expense | 5.60M | 5.30M | 5.70M | 5.70M | 5.60M | 6.00M | 6.20M | 6.50M | 6.60M | 6.90M | 6.20M | 6.50M | 7.40M | 8.50M | 7.90M | 8.30M | 8.70M | 8.10M | 9.10M | 8.20M | 9.70M | 8.60M | 8.10M | 7.70M | 9.00M | 8.60M | 10.30M | 10.10M | 10.10M | 10.10M | 10.60M | 10.60M | 11.60M | 14.00M | 14.00M | 13.60M | 12.70M | 13.60M | 13.70M | 13.20M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 598.50M | 683.20M | 774.40M | 776.40M | 818.80M | 960.90M | 1.01B | 883.40M | 1.31B | 1.48B | 1.51B | 1.19B | 1.48B | 1.96B | 1.95B | 1.85B | 1.78B |
| Gross Profit | 186.20M | 214.10M | 226.40M | 236.40M | 255.20M | 302.00M | 346.00M | 332.30M | 403.30M | 435.00M | 466.20M | 342.70M | 434.90M | 586.70M | 591.10M | 542.90M | 492.40M |
| Operating Income | 20.70M | 72.20M | 47.20M | 96.50M | 90.60M | 112.50M | 156.30M | 98.20M | 125.00M | 133.50M | 149.90M | 33.70M | 132.10M | 187.30M | 161.60M | 177.90M | 129.50M |
| Net Income | 6.40M | 73.70M | 47.10M | 66.90M | 77.80M | 84.10M | 119.50M | - | - | - | - | - | - | - | - | - | - |
| Diluted EPS | 0.26 | 2.97 | 1.92 | 2.81 | 3.22 | 3.38 | 4.86 | 3.33 | 2.52 | 3.45 | 4.54 | 1.16 | 3.75 | 5.32 | 5.56 | 1.42 | 4.67 |
| R&D Expense | 16.40M | 17.60M | 18.30M | 19.60M | 21.20M | 22.20M | 25.30M | 25.40M | 31.40M | 33.40M | 35.40M | 30.90M | 37.40M | 38.70M | 49.00M | 56.50M | 51.00M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 549.40M | 568.80M | 579.40M | 794.70M | 999.90M | 1.03B | 1.18B | 1.41B | 1.47B | 1.47B | 1.40B | 1.57B | 1.60B | 1.71B | 1.73B | 1.83B |
| Total Equity | 229.30M | 157.60M | 300.70M | 343.10M | 317.00M | 409.40M | 515.90M | 605.00M | 653.50M | 793.90M | 825.00M | 918.50M | 944.40M | 1.03B | 1.04B | 1.15B | 1.21B | 1.33B |
| Cash & Equivalents | 13.90M | 68.60M | 107.10M | 76.20M | 22.40M | 80.20M | 41.60M | 136.90M | 101.90M | 90.20M | 123.10M | 75.70M | 105.30M | 141.80M | 147.10M | 203.70M | 289.20M | 292.50M |
| Long Term Debt | - | - | 32.00M | 30.00M | 25.00M | 142.70M | 139.00M | 131.60M | 258.50M | 202.60M | 186.20M | 58.60M | 0 | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - | - | - | - | - | - | - | - | - | 537.90M | 563.30M | 557.80M | 518.60M | 499.50M |
| Current Liabilities | - | - | 158.90M | 146.00M | 147.30M | 155.60M | 222.90M | 206.10M | 183.10M | 261.50M | 296.60M | 303.50M | 252.40M | 336.60M | 405.80M | 371.50M | 371.40M | 360.10M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 87.40M | 58.20M | 34.70M | 61.30M | 61.30M | - | - | 105.50M | 82.70M | 104.90M | 161.60M | 145.90M | 93.20M | 81.70M | 207.30M | 184.50M | 138.30M |
| Investing Cash Flow | -7.20M | -12.80M | -10.70M | -70.30M | -116.10M | - | - | -209.10M | -29.60M | -35.50M | -31.00M | -29.70M | -36.20M | -42.10M | -111.80M | -62.00M | -75.10M |
| Financing Cash Flow | -26.60M | -6.50M | -55.00M | -44.70M | 112.80M | - | - | 69.50M | -66.40M | -36.20M | -177.90M | -86.80M | -20.00M | -33.70M | -39.00M | -35.30M | -63.90M |
| Share Buybacks | 0 | 2.70M | 28.10M | 1.40M | 3.70M | 6.90M | 15.30M | 8.40M | 1.10M | 1.40M | 2.40M | 2.10M | 800.00K | 5.90M | 1.10M | 700.00K | 23.90M |
| Dividends Paid | 1.20M | 0 | 0 | 46.70M | 12.00M | 13.40M | 14.90M | 15.90M | 18.60M | 21.70M | 25.00M | 25.60M | 28.80M | 31.70M | 35.10M | 38.80M | 42.40M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 31.1% | 31.3% | 29.2% | 30.4% | 31.2% | 31.4% | 34.2% | 37.6% | 30.9% | 29.5% | 30.8% | 28.7% | 29.3% | 29.9% | 30.3% | 29.4% | 27.7% |
| Operating Margin % | 3.5% | 10.6% | 6.1% | 12.4% | 11.1% | 11.7% | 15.4% | 11.1% | 9.6% | 9.0% | 9.9% | 2.8% | 8.9% | 9.5% | 8.3% | 9.6% | 7.3% |
| Net Margin % | 1.1% | 10.8% | 6.1% | 8.6% | 9.5% | 8.8% | 11.8% | - | - | - | - | - | - | - | - | - | - |
| ROE % | 4.1% | 24.5% | 13.7% | 21.1% | 19.0% | 16.3% | 19.8% | - | - | - | - | - | - | - | - | - | - |
| ROCE % | - | 18.5% | 11.2% | 22.3% | 14.2% | 14.5% | 19.0% | 9.8% | 10.9% | 11.3% | 12.9% | 2.9% | 10.7% | 15.6% | 12.1% | 13.0% | 8.8% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 15.75% | 3.88M | $319.14M |
| 2 | Allspring Global Investments Holdings, LLC | 9.40% | 2.32M | $190.54M |
| 3 | Vanguard Portfolio Management LLC | 7.55% | 1.86M | $153.04M |
| 4 | Dimensional Fund Advisors LP | 5.04% | 1.24M | $102.19M |
| 5 | Vanguard Capital Management LLC | 4.53% | 1.11M | $91.70M |
| 6 | State Street Corporation | 3.92% | 964.34K | $79.34M |
| 7 | Victory Capital Management Inc. | 3.51% | 864.99K | $71.17M |
| 8 | Nuveen, LLC | 2.61% | 643.25K | $52.92M |
| 9 | Geode Capital Management, LLC | 2.56% | 630.59K | $51.88M |
| 10 | Two Sigma Investments, LP | 2.41% | 593.04K | $48.79M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for IOSP
Dimensional Fund discloses 5.3% Innospec stake (IOSP) - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxOUS1NVk1IcHRLS0xDbWRMeGJuQ1hSbndtaTcxZ0Z3TTRaN1FrMFE4OWhzeXFfSkh1TzdUeTVic2Z2bk5nZVJUMXAtdXUtdG1SY3BDMHdnVVB3TXE1OFl1WjZST0NWLVJzZWlaZDQwdUlHX2hBbGdmZm9kWWhreURsUExGaDNacmRhMWx5Vk…
EMN or IOSP: Which Is the Better Value Stock Right Now? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxQNzdFbTB3MVFTMy12R1JUQTNfTUFqZldmdkxDM2tIZkp1dG5DOFNiUHVlY2Znd0NEeDlpeklwTnJ5aWt6dC00NFZKdkp5dEswNGN2QVZfQWRFYUNZS1hTSUE2MktxejJHZjRkelhFWUFXUVFzT3c5RDhfd2RONXV5UW81OUJRcTlRYVhFTF…
IOSP Forecast — Price Target — Prediction for 2027 - TradingView
<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTE5hVU95Ym1OU2xGV3BEXzJHNHd1SWRPWDdQaDBUQjJWMWdVcWNZY3d6TV9NdFBEWGY1cUVwQ2FOdHExbVFLMDhMYWZKWVNCV2FINTJtZVpSLWdFM1M4THdjUWpDa19FV0VzS21ISWtXSGZGZlFYdGtxaDhR?oc=5" target="_blank">IOS…
Is Innospec (IOSP) Cheap After Its Russell Growth Index Removal? - simplywall.st
<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxPbEpfOHMyMmtZTlg1WmNqNlRpRmNrTlBMTVRmYzNScERuem5FbktqSGJLYzhWU3FLTzVOU1hhTldnOWdnN3N5Y0M3M2ZBS1ZUUVVrWFJRU3EycnAxeV9EaVBSY3lZa2RmMS1FVzNIMnN4aE5KV2Q5T3BhaWpoNHkwTk0zSXotYU9hRXpYb3…
(IOSP) and the Role of Price-Sensitive Allocations - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxPYnNfVjc4ZnNMYzNZWWhwVUw0cDZjVmV6OGVFY3ZCc20tRnVlRmp4UmJQWVFySXBrTlVWQjE2T3ZGX2JnaVUyaWpoM2E0RjhpOWdwTjhEcW5XcnFvbUh6eWVlODR0YlVIeUs5QXBSVTBBUFQ0NUVWZ1B0Wms3TWxXVklMc0hBRXotNEg1NG…
Innospec schedules Aug. 5 call after Q2 2026 results - Stock Titan
<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxQbC1wTjJaRzQtbXNfUGpqYXBUTTF0ZEhHa2RvQ0ZVQjNYVjZ2S09TZmh0bTcyRVI3OWF1U0l1UGpIalYtR2VFb1R1R2JNNzl4S0FFWm4xNmJMd2xDZUZpNVVJQVFLTUM2M1QyLVdnN0lrZXVMNGUzdmp4X3ZyLUVlUzhVRVpSalE0ei1oNG…
IOSP — Frequently Asked Questions
What is the current share price of Innospec Inc. (IOSP)?
As of 2026-07-14 21:23 PDT, Innospec Inc. (IOSP) trades at $81.64 on NasdaqGS. Its 52-week range is $65.12 to $87.39.
What is the market capitalisation of IOSP?
Innospec Inc. (IOSP) has a market capitalisation of $2.01B on NasdaqGS.
What is the P/E ratio of IOSP?
IOSP trades at a trailing price-to-earnings (P/E) ratio of 17.83. The industry average P/E is 22.91. Its price-to-book (P/B) ratio is 1.59.
Does IOSP pay a dividend?
Innospec Inc. (IOSP) currently offers a dividend yield of 2.07%.
What is the return on equity (ROE) of IOSP?
IOSP has a return on equity (ROE) of 8.69%. Its return on capital employed (ROCE) is 8.80%.
Is IOSP a good stock to buy?
This page provides a data-driven analysis of Innospec Inc. (IOSP), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.